Dr. Lal PathLabs

Dr. Lal PathLabs FCF Yield

The Free Cash Flow Yield of Dr. Lal PathLabs (LALPATHLAB.NS) as of Oct 24, 2026 is 2.41 %. In the previous year, Free Cash Flow Yield was 2.36 % — a change of 2.00% (higher).

FCF Yield

2.41 %

YoY

2.00%

Last updated:

Free Cash Flow Yield of Dr. Lal PathLabs is 2026 2.41 % . Free Cash Flow Yield of Dr. Lal PathLabs was 2025 2.36 % . It decreases by 2.00% higher compared to the previous year.

The Dr. Lal PathLabs FCF Yield history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Yield
Date
FCF Yield
Jan 1, 2019
0.79 INR
Jan 1, 2020
0.92 INR
Jan 1, 2021
1.52 INR
Jan 1, 2022
-0.13 INR
Jan 1, 2023
1.85 INR
Jan 1, 2024
2.18 INR
Jan 1, 2025
2.36 INR
Jan 1, 2026
2.41 INR
The Dr. Lal PathLabs FCF Yield history
YEARFCF YieldYoY
2.41 %+2.00%
2.36 %+8.33%
2.18 %+17.69%
1.85 %-1,496.99%
-0.13 %-108.70%
1.52 %+65.74%
0.92 %+15.74%
0.79 %+41.66%
0.56 %+3.79%
0.54 %+16.86%
0.46 %+64.21%
0.28 %-4.05%
0.29 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Dr. Lal PathLabs Stock analysis

What does Dr. Lal PathLabs do? Dr. Lal PathLabs Ltd is a leading diagnostic company in India, offering a wide range of tests and services. The company was founded in 1949 by Dr. S.K. Lal in Delhi and has since expanded its services throughout India. Business Model: The business model of Dr. Lal PathLabs Ltd is based on offering diagnostic test packages for various diseases and disorders. Customers can choose from different test packages tailored to their specific needs. The company utilizes state-of-the-art technology and equipment in its laboratories to deliver accurate results. Another important pillar of the business model is close collaboration with doctors and clinics to improve customer care and provide comprehensive medical services. Company History: Dr. Lal PathLabs Ltd began its journey in 1949 in Delhi, India, when Dr. S.K. Lal founded the company. It was one of the few private laboratories capable of conducting diagnostic tests and was a pioneer in developing modern technology and equipment to support the tests. Over the years, the company has expanded its operations and services and is now one of the leading diagnostic companies in India. It is known for its precise test results, excellent customer care, and innovative technology. Segments: Dr. Lal PathLabs Ltd offers a wide range of diagnostic tests and services. The various segments covered by the company include: 1. Clinical Pathology: This segment covers a wide range of tests targeting the customers' health condition. They include blood tests, urine and stool tests, hormone tests, diabetes checks, pregnancy tests, and more. 2. Microbiology: This segment deals with the identification of pathogens such as bacteria, viruses, fungi, and parasites found in tests of body fluids and tissue samples. 3. Histology: This segment covers the identification of tissue samples and cells. It is used in the diagnosis of cancer, thyroid disorders, and other diseases. 4. Immunology: Tests are conducted based on antibodies to diagnose autoimmune diseases, infectious diseases, and allergies. 5. Genetics: This segment deals with the diagnosis of genetic diseases and genetic testing for disease prevention. Products: Dr. Lal PathLabs Ltd offers a wide range of diagnostic test packages customized to individual customer needs. Some of the key test packages include: 1. Pro 1: This test package provides a comprehensive evaluation of all key parameters, including cholesterol, blood pressure, and uric acid. 2. Essential Health Checkup: This test package is designed for checking heart health and includes tests such as electrocardiogram (EKG), lipid profile, and complete blood count. 3. Diabetic Profile: This test package is specifically designed for diabetics and includes tests such as HbA1c, kidney function tests, and lipid profile. 4. Comprehensive Health Checkup: This test package offers a comprehensive evaluation of all key parameters, including cholesterol, blood pressure, blood sugar, and uric acid. Dr. Lal PathLabs Ltd has established itself as a leading diagnostic company in India and is known for its high accuracy in test results and innovative technology. The company is committed to improving medical care and works closely with doctors and clinics to provide comprehensive medical services. Dr. Lal PathLabs is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Dr. Lal PathLabs stock

Free Cash Flow Yield of Dr. Lal PathLabs is 2.41 % in 2026.

Free Cash Flow Yield of Dr. Lal PathLabs changed from 2.36 % to 2.41 %, representing a 2.00% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow Yield Dr. Lal PathLabs since 2006 – with annual values, charts, and detailed analysis.

FCF Yield measures the free cash flow per share relative to the stock price. It indicates how much cash a company generates for each dollar invested.

To evaluate Free Cash Flow Yield's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Free Cash Flow Yield.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow Yield's Dr. Lal PathLabs with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Dr. Lal PathLabs

All Key Metrics — Dr. Lal PathLabs